Cure Therapies for HIV
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore how potential HIV cure therapies affect the virus and immune cells in the gut. Participants will undergo a colonoscopy, a procedure using a camera to inspect the colon, to collect tissue samples. Researchers will examine these samples for changes in immune cells and viral levels. People living with chronic HIV-1, who are on treatment aiming for a cure and comfortable with undergoing a colonoscopy, may be a good fit for this study. As an unphased trial, this study offers participants a unique opportunity to contribute to groundbreaking research in HIV cure strategies.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, it mentions that participants must be receiving treatment with a molecule that has the potential for an HIV cure.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Studies have shown that some HIV cure therapies can be safe for participants. In one program, participants reported no harmful effects, suggesting that the treatments might be easy to handle. Another study followed a drug called maraviroc for five years, and it was generally safe for those who had used other HIV treatments before. It's important to note that health authorities have not yet approved all HIV cure therapies. While some early results are promising, researchers continue to learn about the safety of these treatments.12345
Why are researchers excited about this trial?
Unlike the standard HIV treatments, which typically involve antiretroviral drugs to manage the virus, this trial is exploring colonoscopy as a potential avenue for an HIV cure. Researchers are excited about this approach because it could uncover new insights into how the gastrointestinal tract might play a role in eliminating the virus from the body. This method is unique as it focuses on a physical procedure rather than medication, potentially paving the way for groundbreaking discoveries in the fight against HIV.
What evidence suggests that this trial's treatments could be effective for HIV?
Studies have shown that treatments for HIV aim to control the virus without ongoing medication. Although a universal cure does not yet exist, researchers are exploring various approaches. In this trial, participants will receive therapies with potential for an HIV cure. Some studies suggest that widespread use of these treatments could significantly reduce new HIV cases. However, effectiveness can vary, and further research is needed to understand long-term effects. The primary goal is to find a treatment that manages the virus and enhances life for people with HIV.16789
Who Is on the Research Team?
Francesca Cossarini
Principal Investigator
Icahn School of Medicine at Mount Sinai
Are You a Good Fit for This Trial?
This trial is for adults aged 18-75 with chronic HIV infection who are willing to follow the study procedures. They must be able to undergo a colonoscopy twice and be on a treatment that might cure HIV. People with bowel diseases, other gastrointestinal conditions, coagulation problems, or those pregnant or planning pregnancy can't participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Subjects receive therapies with the potential for HIV cure and undergo a colonoscopy to obtain gastrointestinal tissue for research assays
Follow-up
Participants are monitored for changes in immune cells and HIV viral load in the gastrointestinal tract
What Are the Treatments Tested in This Trial?
Interventions
- Colonoscopy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Icahn School of Medicine at Mount Sinai
Lead Sponsor